All studies
CompletedPhase IIIInterventional

A trial of common mucoactives used to help airway clearance in patients with respiratory failure requiring mechanical ventilation

Very sick patients in intensive care often need a breathing machine (ventilator) to help them get enough oxygen. While on a machine, thick phlegm or mucus can build up in the lungs, making breathing harder and raising the chance of a chest infection. Doctors often try mucus-thinning medicines to help, but there is little proof showing how well they work in intensive care. This UK trial tests two common treatments: carbocisteine (given into a feeding tube to thin sticky mucus) and hypertonic saline (a salty water mist breathed in through a mask or tube to trigger coughing). Patients are randomly assigned to receive one, both, or neither of these medicines alongside standard chest care. The study aims to find out if these medicines help patients breathe on their own sooner and shorten their stay in intensive care.

At a glance

Status
Completed
Phase
Phase III
Sponsor
Belfast Health and Social Care Trust
Enrolment target
1,956
Start
17 Feb 2022
Estimated completion
30 Apr 2025

What is this study about?

When someone becomes critically ill, their lungs may suddenly struggle to take in enough oxygen. This is known as acute respiratory failure. In an intensive care unit (ICU), doctors often connect patients to a mechanical ventilator—a machine that breathes for them through a tube placed in their airway. While life-saving, having a breathing tube makes it very hard to cough up natural chest mucus. If this sticky phlegm builds up, it can clog the airways and cause serious lung infections.

To help keep airways clear, doctors and physiotherapists use regular suctioning, air humidification, and chest exercises. Sometimes, doctors also prescribe mucus-clearing medicines called 'mucoactives'. Two popular types are carbocisteine, a medicine that breaks down thick, sticky mucus, and hypertonic saline, which is a sterile salty water mist that helps loosen phlegm. Both are widely used for chronic lung conditions, but doctors still do not know for sure if they speed up recovery for critically ill patients on ventilators.

This nationwide UK study, called the MARCH trial, compares these two medicines to standard airway care. By testing whether either treatment—or a combination of both—helps clear secretions more effectively, researchers hope to see if patients can come off breathing machines sooner, spend less time in intensive care, and recover with fewer complications.

Key takeaways

  • Tests two common mucus-clearing medicines in people needing breathing machines in intensive care.
  • Aims to find out if thinning lung mucus helps patients come off ventilators sooner.
  • Patients receive either carbocisteine, a salty water mist, both, or standard chest care alone.
  • Treatments are given in the hospital for up to 28 days, followed by simple home check-in surveys at 2 and 6 months.
  • Participation is voluntary and does not interfere with standard, round-the-clock intensive care.

Who may be eligible?

This study is designed for patients aged 16 and over who are currently being cared for in an intensive care unit and need a mechanical breathing machine for at least 48 hours. To take part, the patient's medical team must feel that they have thick or troublesome chest secretions that are proving difficult to clear using usual care techniques.

Patients cannot take part if they were already regularly using these mucus-thinning medicines at home for a long-term chest condition before coming to hospital, or if they have known allergies to them. Pregnant women and patients whose intensive care treatment is sadly being withdrawn within the next 24 hours are also not eligible.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. Patient is aged 16 or over.
  2. Patient is currently in an intensive care unit (ICU).
  3. Patient is breathing through a mechanical ventilator tube (expected for at least 48 hours).
  4. Patient has thick chest mucus that is hard to clear with standard care.
  5. Patient was not already taking regular mucoactive medicines before this hospital stay.
  6. Patient is not pregnant.
Answer every question to see your result.

What does participation involve?

Because patients on breathing machines are often sedated, entry into the study is usually discussed with a close family member or personal representative first. Once enrolled, a computer randomly places the patient into one of four groups: standard chest care alone, standard care with carbocisteine, standard care with hypertonic saline mist, or standard care with both medicines.

Carbocisteine is given three times a day through the patient's existing feeding tube. Hypertonic saline is given four times a day as a gentle mist through the breathing circuit. These treatments continue for as long as the patient needs intensive care, up to a maximum of 28 to 30 days. The clinical team will collect routine blood and mucus samples to see how the medicines work in the body.

After leaving the intensive care unit, patients (or their families) are asked to fill in a short quality-of-life questionnaire. Two further simple questionnaires are sent by post or email at 2 months and 6 months after leaving hospital to check on long-term recovery and any ongoing healthcare needs.

Potential risks and benefits

Taking part may not directly benefit the patient, but the findings could greatly improve care for future critically ill people. Both medicines are already widely used across the NHS. However, like all medications, they can cause side effects such as tummy upset or airway irritation. Doctors monitor patients around the clock in the ICU, and if any problems occur, the medicine can be stopped right away. Taking part is completely voluntary, and family members or patients can choose to withdraw from the trial at any point without it affecting the quality of standard NHS medical care in any way.

Locations (77)

  • Royal Liverpool University Hospital
    Approximate
    Liverpool, England
  • Altnagelvin Area Hospital
    City only
    Londonderry, Northern Ireland
  • Antrim Area Hospital
    Approximate
    Antrim, Northern Ireland
  • Barnsley District General Hospital
    Approximate
    Barnsley, England
  • Queen Elizabeth Hospital
    Approximate
    Birmingham, England
  • Bristol Royal Infirmary
    Unverified
    Bristol, England
  • Royal Infirmary of Edinburgh
    Unverified
    Lothian, Scotland
  • Freeman Hospital
    Unverified
    Newcastle upon Tyne, England
  • The Royal Victoria Infirmary
    Unverified
    Newcastle upon Tyne, England
  • Glasgow Royal Infirmary
    Unverified
    Glasgow, Scotland
  • Gloucester Royal Hospital
    Unverified
    Gloucester, England
  • Guy's Hospital
    Unverified
    London, England

Common questions

What is a mucoactive medicine?

A mucoactive is a type of medicine that helps the body clear mucus from the lungs, either by making sticky phlegm thinner and more watery, or by stimulating the airways to cough it up.

How can a patient agree to join if they are asleep or sedated?

In emergency intensive care research, researchers talk to a family member or partner to ask if they think the patient would be happy to take part. Once the patient is awake and recovered, the study is explained to them directly so they can decide whether to stay involved.

Will taking part replace usual intensive care treatment?

No. All patients receive full, standard intensive care, including routine suctioning, humidified air, and chest physiotherapy. The study medicines are added on top of usual care.

Do patients have to travel for follow-up appointments?

No extra hospital visits are needed for the study. The follow-up checks at 2 and 6 months are simple forms sent by post or email to complete at home.

Can a patient leave the study if they change their mind?

Yes. A patient or their family can leave the study at any time without giving a reason. Withdrawing will never change or harm their normal medical care.

How to find out more

Naomi Dickson

Always speak to your GP or specialist before deciding to take part in a study.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.